Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Meer

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Mammalian Genome : Official Journal of the International Mammalian Genome Society|November 15, 2001
Map Manager QTX, cross-platform software for genetic mappingK F Manly, R H Cudmore, J M Meer
Cancer Immunology, Immunotherapy : CII|November 7, 1999
Measurement of low-abundance cytokine mRNA in cells of murine lymphoid organs: a new quantitative reverse transcription/polymerase chain reaction methodE S Berleth, P Ujhazy, J M Meer, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 1998
Doxorubicin plus tumor necrosis factor alpha combination treatments in EL4-lymphoma-bearing C57BL/6 miceM J Ehrke, S Verstovsek, P Ujházy, et al.
International Journal of Cancer|May 20, 1998
Thymic anti-tumor effectors in mice cured of lymphoma by cyclophosphamide plus TNF-alpha therapy: phenotypic and functional characterization up to 20 months after initial tumor inoculationM J Ehrke, S Verstovsek, S K Pocchiari, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Mammalian Genome : Official Journal of the International Mammalian Genome Society|November 15, 2001
Map Manager QTX, cross-platform software for genetic mappingK F Manly, R H Cudmore, J M Meer
Cancer Immunology, Immunotherapy : CII|November 7, 1999
Measurement of low-abundance cytokine mRNA in cells of murine lymphoid organs: a new quantitative reverse transcription/polymerase chain reaction methodE S Berleth, P Ujhazy, J M Meer, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 1998
Doxorubicin plus tumor necrosis factor alpha combination treatments in EL4-lymphoma-bearing C57BL/6 miceM J Ehrke, S Verstovsek, P Ujházy, et al.
International Journal of Cancer|May 20, 1998
Thymic anti-tumor effectors in mice cured of lymphoma by cyclophosphamide plus TNF-alpha therapy: phenotypic and functional characterization up to 20 months after initial tumor inoculationM J Ehrke, S Verstovsek, S K Pocchiari, et al.
Pageof 1